Reports - Synthetic Cannabinoids Market
HealthcareSynthetic Cannabinoids Market
Synthetic Cannabinoids Market: Solutions, Growth & Trends | 2025-2035 by Product Type (High-pure, Ultra-pure, Other Product Types) by Distribution Channel (Drugstore & Pharmacy, Online Pharmacy, Physical Store, Other Distribution Channels) by End User (Research & Development Institution, Pharmaceutical & Biotechnology Company, Forensic Laboratory, Others End-Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Synthetic Cannabinoids Market - Segment Analysis
1. Overview
2. Global Synthetic Cannabinoids Market, 2021 - 2035 (USD Million)
3. Global Synthetic Cannabinoids Market - by Product Type
3.1. By High-pure
3.2. By Ultra-pure
3.3. By Other Product Types
4. Global Synthetic Cannabinoids Market - by Distribution Channel
4.1. By Drugstore & Pharmacy
4.2. By Online Pharmacy
4.3. By Physical Store
4.4. By Other Distribution Channels
5. Global Synthetic Cannabinoids Market - by End User
5.1. By Research & Development Institution
5.2. By Pharmaceutical & Biotechnology Company
5.3. By Forensic Laboratory
5.4. By Others End-Users
6. Global Synthetic Cannabinoids Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Synthetic Cannabinoids Market - Segment Analysis
1. Overview
2. North America Synthetic Cannabinoids Market, 2021 - 2035 (USD Million)
3. North America Synthetic Cannabinoids Market - by Product Type
3.1. By High-pure
3.2. By Ultra-pure
3.3. By Other Product Types
4. North America Synthetic Cannabinoids Market - by Distribution Channel
4.1. By Drugstore & Pharmacy
4.2. By Online Pharmacy
4.3. By Physical Store
4.4. By Other Distribution Channels
5. North America Synthetic Cannabinoids Market - by End User
5.1. By Research & Development Institution
5.2. By Pharmaceutical & Biotechnology Company
5.3. By Forensic Laboratory
5.4. By Others End-Users
Chapter 5 Europe Synthetic Cannabinoids Market - Segment Analysis
1. Overview
2. Europe Synthetic Cannabinoids Market, 2021 - 2035 (USD Million)
3. Europe Synthetic Cannabinoids Market - by Product Type
3.1. By High-pure
3.2. By Ultra-pure
3.3. By Other Product Types
4. Europe Synthetic Cannabinoids Market - by Distribution Channel
4.1. By Drugstore & Pharmacy
4.2. By Online Pharmacy
4.3. By Physical Store
4.4. By Other Distribution Channels
5. Europe Synthetic Cannabinoids Market - by End User
5.1. By Research & Development Institution
5.2. By Pharmaceutical & Biotechnology Company
5.3. By Forensic Laboratory
5.4. By Others End-Users
Chapter 6 Asia Pacific Synthetic Cannabinoids Market - Segment Analysis
1. Overview
2. Asia Pacific Synthetic Cannabinoids Market, 2021 - 2035 (USD Million)
3. Asia Pacific Synthetic Cannabinoids Market - by Product Type
3.1. By High-pure
3.2. By Ultra-pure
3.3. By Other Product Types
4. Asia Pacific Synthetic Cannabinoids Market - by Distribution Channel
4.1. By Drugstore & Pharmacy
4.2. By Online Pharmacy
4.3. By Physical Store
4.4. By Other Distribution Channels
5. Asia Pacific Synthetic Cannabinoids Market - by End User
5.1. By Research & Development Institution
5.2. By Pharmaceutical & Biotechnology Company
5.3. By Forensic Laboratory
5.4. By Others End-Users
Chapter 7 Latin America Synthetic Cannabinoids Market - Segment Analysis
1. Overview
2. Latin America Synthetic Cannabinoids Market, 2021 - 2035 (USD Million)
3. Latin America Synthetic Cannabinoids Market - by Product Type
3.1. By High-pure
3.2. By Ultra-pure
3.3. By Other Product Types
4. Latin America Synthetic Cannabinoids Market - by Distribution Channel
4.1. By Drugstore & Pharmacy
4.2. By Online Pharmacy
4.3. By Physical Store
4.4. By Other Distribution Channels
5. Latin America Synthetic Cannabinoids Market - by End User
5.1. By Research & Development Institution
5.2. By Pharmaceutical & Biotechnology Company
5.3. By Forensic Laboratory
5.4. By Others End-Users
Chapter 8 Middle East & Africa Synthetic Cannabinoids Market - Segment Analysis
1. Overview
2. Middle East & Africa Synthetic Cannabinoids Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Synthetic Cannabinoids Market - by Product Type
3.1. By High-pure
3.2. By Ultra-pure
3.3. By Other Product Types
4. Middle East & Africa Synthetic Cannabinoids Market - by Distribution Channel
4.1. By Drugstore & Pharmacy
4.2. By Online Pharmacy
4.3. By Physical Store
4.4. By Other Distribution Channels
5. Middle East & Africa Synthetic Cannabinoids Market - by End User
5.1. By Research & Development Institution
5.2. By Pharmaceutical & Biotechnology Company
5.3. By Forensic Laboratory
5.4. By Others End-Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Mylan N.V. (U.S.)
2. Noramco. (U.S.)
3. HYASYNTH Biologicals Inc. (Canada)
4. Renew Biopharma Inc. (U.S.)
5. Ginkgo Bioworks (U.S.)
6. CV Sciences Inc. (U.S.)
7. Anandia Labs (Canada)
8. The Cronos Group (Canada)
9. Biotii Technologies Corp. (Canada)
10. Bristol-Myers Squibb Company (U.S.)
11. GW Pharmaceuticals PLC (UK)
12. AbbVie Inc. (U.S.)
13. Isodiol International Inc. (Canada)
14. CURE Pharmaceutical (U.S.)
15. Zynerba Pharmaceuticals Inc. (U.S.)
16. Aphios Corp. (U.S.)
17. Botanix Pharmaceuticals (U.S.)
18. BioVectra (Canada)
19. INMED Pharmaceuticals Inc. (Canada)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By